Oct 8 (Reuters) -
ARTHROSI SECURES $153 MILLION IN SERIES E FINANCING TO COMPLETE PIVOTAL DEVELOPMENT OF POZDEUTINURAD FOR THE TREATMENT OF GOUT AND TOPHACEOUS GOUT
ARTHROSI THERAPEUTICS : FINANCING LED BY PRIME EIGHT CAPITAL LIMITED, PARTICIPATION FROM CR BIOTECH,HIGHLIGHT CAPITAL, OTHERS
Further company coverage: [ ]